NR1H4 and metabolic dysfunction-associated steatotic liver disease: BA metabolism is intimately connected to lipid homeostasis, thus FXR is an important modulator of lipid metabolism as well, and has gained attention as a therapeutic target in the treatment of non-alcoholic fatty liver disease [28,29,30,31].